Related Experiment Videos
Adverse effects of (15S)-15-methyl-prostaglandin E1 in normal and paraquat-exposed rats
J H Williams1, R D Fairshter, T R Ulich
1Department of Medicine, University of California, Irvine 92668.
Abstract:
Single, daily injections of approximately 1 mg/kg of (15S)-15-methyl-PGE1 (mPGE1), a PGE1 analog, have been reported to inhibit inflammation and to prolong survival in several animal models of local and systemic inflammation. We examined the effect of this dose of mPGE1 on paraquat toxicity in rats. A significant increase in early mortality was identified in mPGE1-treated rats as early as 3 hr following injection of paraquat and appeared associated with increased respiratory effort. Rats given mPGE1 without paraquat also appeared to increase respiratory effort but did not die. Rats killed at 3 hr following injections demonstrated increased lung weights in both paraquat-injected and control animals receiving mPGE1. Although a neutrophilia was identified in these animals, no significant increase in lung lavage neutrophils or albumin was identified. These data suggest that large intermittent doses of a PGE1 analog may adversely affect the respiratory system of normal and injured animals, and will accelerate mortality following exposure to potentially lethal doses of paraquat.
Insights
High doses of a prostaglandin E1 analog (mPGE1) accelerated mortality in rats exposed to paraquat. This prostaglandin analog also appeared to negatively impact the respiratory system in both healthy and injured animals.
Area of Science:
- Toxicology
- Pharmacology
- Respiratory Medicine
Background:
- Prostaglandin E1 (PGE1) analogs, such as (15S)-15-methyl-PGE1 (mPGE1), are known for their anti-inflammatory properties.
- Previous studies indicated that mPGE1 can prolong survival in animal models of inflammation.
Purpose of the Study:
- To investigate the effects of mPGE1 on paraquat toxicity in a rat model.
- To determine if mPGE1 influences mortality rates and physiological responses following paraquat exposure.
Main Methods:
- Rats were administered mPGE1 (1 mg/kg) daily, with some groups also receiving paraquat.
- Mortality, respiratory effort, lung weights, and lung lavage fluid parameters (neutrophils, albumin) were assessed at various time points.
Main Results:
- mPGE1 administration significantly increased early mortality in rats exposed to paraquat, observed as early as 3 hours post-injection.
- Increased respiratory effort was noted in mPGE1-treated rats, both with and without paraquat, although only paraquat-exposed rats showed increased mortality.
- Elevated lung weights were observed in rats receiving mPGE1, irrespective of paraquat administration, suggesting a direct effect on lung tissue.
Conclusions:
- Intermittent, high-dose administration of mPGE1 may adversely affect the respiratory system in rats.
- mPGE1 can accelerate mortality in animals exposed to potentially lethal doses of paraquat.
- The findings suggest a potential risk associated with using high-dose PGE1 analogs in patients with lung injury or exposure to toxins.